Elevated adenosine deaminase activity in overweightand obese Indian subjects

Archives of Physiology and Biochemistry

Volumn 118, Issue 1, 2012, Pages 1-5

  Jadhav, Ashish Anantrao ^a   Jain, Anuradha ^a  

^a People s College of Medical Sciences and Research Centre   (India)

Author keywords

Adenosine; Adenosine deaminase; Diabetes; Obesity; Overweight

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; INOSINE;

ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; DIET RESTRICTION; ENZYMOLOGY; FEMALE; HUMAN; INDIA; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY;

ADENOSINE; ADENOSINE DEAMINASE; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; BODY COMPOSITION; BODY MASS INDEX; FASTING; FEMALE; HUMANS; INDIA; INOSINE; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY;

EID: 84856609814     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813455.2011.603341     Document Type: Article

References (59)

1. Adanin S, Yalovetskiy IV, Nardulli BA, Sam II AD, Jonjev ZS, Law WR. (2002). Inhibiting adenosine deaminase modulates the systemic infammatory response syndrome in endotoxemia and sepsis. Am J Physiol Regul Integr Comp Physiol 282:R1324-32 (Pubitemid 34664516)
2. Amatruda JM, Statt MC, Welle SL. (1993). Total and resting energy expenditure in obese women reduced to ideal body weight. J Clin Invest, 92:1236-42. (Pubitemid 23273897)
3. Bastard JP, Jardel C, Bruckert E, Blondy P, Capeau J, Laville M, Vidal H, Hainque B. (2000). Elevated levels of interleukins 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endrocrinol Metab 85:3338-42.
4. Borensztajn J. (1987). Heart and skeletal muscle lipoprotein lipase. In: Borensztajn, J., editor. Lipoprotein lipase. Chicago: Evener, pp. 133-48.
5. Bottini E, Gloria-Bottini F. (1999). Adenosine deaminase and body mass index in non-insulin-dependent diabetes mellitus. Metabolism 48:949-51. (Pubitemid 29374908)
6. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA. (1994). Diferential regulatory efects of adenosine on cytokine release by activated human monocytes. J Immunol 153:4159-68. (Pubitemid 24322583)
7. Caro JF, Sinha MK, Kolaczybski JW, Zhang PL, Consdine RV. (1996). Leptin: the tale of an obesity gene. Diabetes 45:1455-62. (Pubitemid 26357535)
8. Clinical Guidelines on the Identifcation, Evaluation, and Treatment of Overweight and Obesity in Adults. 1998). Bethesda, MD: National Institutes of Health. Available online at: http://www.nhlbi.nih. gov/guidelines.
9. Cronstein BN. (1994). Adenosine, an endogenous anti-infammatory agent. J Appl Physiol 76:5-13.
10. Cronstein BN, Eberle MA, Gruber HE, Levin RI. (1991). Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 88:2441-5. (Pubitemid 21916433)
11. Cronstein BN, Montesinos MC, Weissmann G. (1999). Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFκB. Proc Natl Acad Sci USA 96:6377-81. (Pubitemid 29256673)
12. Cronstein BN, Naime D, Firestein GS. (1995). Te anti-infammatory efects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum 38:1040-45.
13. Cruciani F, Bernardini L, Santolamazza P, Modiano D, Torroni A, Scozzari R. (2003). Linkage disequilibrium analysis of the human adenosine deaminase (ada) gene provides evidence for a lack of correlation between hot spots of equal and unequal homologues recombinant. Genomics 82:20-33. (Pubitemid 36693917)
14. Cryer A. (1987). Comparative biochemistry and physiology of lipoprotein lipase. In: Borensztajn, J., editor. Lipoprotein lipase. Chicago: Evener, pp. 277-327.
15. Dhingra V, Chatterjee A, Guleria R, Sharma R, Pandey RM, Talwar KK, Misra A. (2002). Adverse physical activity pattern in urban adolescents (Abstract). J Assoc Physicians India 50:1521.
16. Eigler A, Greten TF, Sinha B, Haslberger C, Sullivan GW, Endres S. (1997). Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis. Scand J Immunol 45:132-39. (Pubitemid 27047241)
17. Firestein GS, Boyle D, Bullough DA, Gruber HE, Sajjadi FG, Montag A, Sambol B, Mullane KM. (1994). Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol 152:5853-9. (Pubitemid 24174165)
18. Flier JS. (1995). Te adipocytes: storage depot or node on the energy information superhighway? Cell 80: 15-18.
19. Fried SK, Zechner R. (1989). Cachectin/tumour necrosis factor decreases human adipose tissue lipoprotein lipase m RNA levels, synthesis, and activity. J Lipid Res 30:1917-23. (Pubitemid 20030370)
20. Gadangi P, Longaker M, Naime D, Levin RI, Recht PA, Montesinos MC, Buckley MT, Carlin G, Cronstein BN. (1996). Te anti-infammatory mechanism of sulfasalazine is related to adenosine release at infamed sites. J Immunol 156:1937-41. (Pubitemid 26069328)
21. Gopinath N, Chadha SL, Jain P, Shekhawat S, Tandon R. (1994). An epidemiological study of obesity in adults in the urban population of Delhi. J Assoc Physician India 42:212-15.
22. Green A. (1987). Adenosine receptor down-regulation and insulin resistance following prolonged incubation of adipocytes with an A1 adenosine receptor agonist. J Biol Chem 262:15702-7.
23. Grunfeld CR, Gulli AH, Moser LA, Gavin KR. (1989). Efect of tumour necrosis factor administration in vivo on lipoprotein lipase activity in various tissues of the rat. J Lipid Res 30: 579-85.
24. Gupta AK, Ahmad AJ. (1990). Childhood obesity and hypertension. Indian Pediatr 27: 333-37.
25. Hasko G, Czabo C, Nemeth ZH, Kvetan V, Pastores SM, Vizi ES. (1996). Adenosine receptor agonists diferentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264, 7 macrophage and in endotoxemic mice. J Immunol 157:4634-40. (Pubitemid 126449386)
26. Hollenberg CH. (1966). Te origin and glyceride distribution of fatty acids in rat adipose tissue. J Clin Invest 45:205-16.
27. Hoshino T, Yamada K, Masuoka K, Tsuboi I, Itoh K, Nonaka K, Oizumi K. (1994). Elevated adenosine deaminase activity in the serum of patients with diabetes mellitus. Diabetes Res Clin Pract 25: 97-102. (Pubitemid 24306147)
28. Hotamisligil GS. (2003). Infammation, TNF-α and insulin resistance. In: Leroith D, Taylor SI, Olefsky JM, editors. Diabetes mellitus. Philadelphia, USA: Lippincott-Raven Publishers.
29. Hotamisligil GS, Budavari D, Murray D, Spiegelman BM. (1994). Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumour necrosis factor-α. J Clin Invest 94: 1543-9.
30. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. (1996). IRS-1 mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 271:665-8. (Pubitemid 26052915)
31. Hotamisligil GS, Shargill NS, Spiegelman BM. (1993). Adipose expression of tumour necrosis factor α: direct role in obesity-linked insulin resistance. Science (Wash DC) 259:87-91. (Pubitemid 23036092)
32. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A. (1995). Tumour necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270:23780-84.
33. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. (1995). Te expression of tumour necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95:2111-19.
34. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. (1972). Indices of relative weight and obesity. J Chronic Dis 25:329-43.
35. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. (1994). Increasing prevalence of overweight among US adults. JAMA 272:205-11.
36. Kurtul N, Akarsu E, Aktaran S. (2006). Te relationship between serum total sialic acid levels and adenosine deaminase activity in obesity. Saud Med J 27:170-73.
37. Lembertas AV, Perusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C. (1997). Identifcation of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 100:1240-47 (Pubitemid 27386310)
38. Linden J. (1991). Structure and function of A1 adenosine receptors. FASEB J 5:2668-76.
39. Linden J. (1994). Cloned adenosine A3 receptors: pharmacological properties, species diferences and receptor functions. Trends Pharmacol Sci 15:298-306.
40. Lohman TG, Roche AF, Martorell R eds.(1988). Anthropometric standardization reference manual. Champaign, IL: Human Kinetics Books.
41. Mc Whinney CD, Dudley MW, Bowlin TL, Peet NP, Schook L, Bradshaw M, De M, Borcherding DR, Edwards CK III. (1996). Activation of adenosine A3 receptors on macrophage inhibits tumour necrosis factor-α. Eur J Pharmacol 310:209-16. (Pubitemid 26298264)
42. Miller WC, Lindeman AK, Wallace J, Niedepruem M. (1990). Diet composition, energy intake, and exercise in relation to body fat in men and women. Am J Clin Nutr 52:426-30.
43. Misra A, Pandey RM, Devi JR, Sharma R, Vikram NK, Khanna N. (2001). High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord 25:1722-9. (Pubitemid 33052085)
44. Mohamed-Ali V, Pinkney JH, Coppack SW. (1998). Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22:1145-58. (Pubitemid 28548534)
45. Mohan V. (2004). Why are Indians more prone to diabetes? J Assoc Physicians India 52:468-74. (Pubitemid 41315478)
46. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R. (2001). Intra-urban diferences in the prevalence of the metabolic syndrome in southern India- the Chennai Urban Population Study (CUPS No.4). Diabet Med 18:280-87. (Pubitemid 32579357)
47. Monga S. (2004). Obesity among school children (7-9 years old) in India: Prevalence and related factors. American Public Health Association: Washington, DC
48. Ongini E, Fredholm BB. (1996). Pharmacology of adenosine A2A receptors. Trends Pharmacol Sci 17:364-72.
49. Patton JS, Shepard HM, Wilking H, Lewis G, Aggarwal BB, Eessalu TE, Gavin LA, Grunfeld C. (1986). Interferons and tumour necrosis factors have similar catabolic efects on 3T3-L1 cells. Proc Natl Acad Sci USA 83:8313-17. (Pubitemid 17182491)
50. Ramos EJ, Xu Y, Romanova I, Middleton F, Chen C, Quinn R, Inui A, Das U, Meguid MM. (2003). Is obesity an infammatory disease? Surgery 134:329-35.
51. Randle PJ, Garland PB, Hales CN, Newsholme EA. (1963). Te glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281:785-9.
52. Sajjadi FG, Tabayashi K, Foster AC, Domingo RC, Firestein GS. (1996). Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors. J Immunol 156:3435-42. (Pubitemid 26124449)
53. Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. (1998). Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol 66:65-72. (Pubitemid 28451680)
54. Spencer N, Hopkinson D, Harris H. (1968). Adenosine deaminase polymorphism in man. Ann Hum Genet 32:9-14.
55. Spiegelman BM, Choy L, Hotamisligil GS, Graves RA, Tontonoz P. (1993). Regulation of adipocyte gene expression in diferentiation and syndromes of obesity/diabetes. J Biol Chem 268:6823-6. (Pubitemid 23105553)
56. Stephens JM, Pekala PH. (1991). Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumour necrosis factor-α. J Biol Chem 266:21839-45. (Pubitemid 121000258)
57. Wang Y Chen HJ, Shaikh S, Mathur P. (2009). Is obesity becoming a public health problem in India? Examine the shift from under-to overnutrition problems over time. Obes Rev 10:456-74.
58. Wild S, Roglic G, Green A, Sicree R, King H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-53. (Pubitemid 38579764)
59. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nicholas A, Ross JS, Tartaglia LA, Chen H. (2003). Chronic infammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821-30. (Pubitemid 38063705)